DTIL vs NCLH · rev $10.8M vs P/E 16, rev $4.97B
Precision BioSciences Inc (DTIL) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
DTIL currently screens at market cap $48.1M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the DTIL and NCLH stock pages for the full models.
Not investment advice.